Diskussion:David A. Sinclair

Relevant

Da er als Professor und Unternehmer erfolgreich ist und als ein führender Altersforscher angesehen wird ist die Relevanz gegeben.

Es gibt bereits einen englischen Artikel

Ich werde weitere Daten ermitteln und nach dem Geb Datum suchen --Alia 2005 (Diskussion) 08:52, 21. Dez. 2013 (CET)

Mail

Hi from Germany

Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@... Datum: 22.12.2013 00:25

Hi Alia,

Im David SInclair, age 44, born sydney Australia.

Here is my CV. School was St. Ives High School, Sydney. Married, 3 children.

Thanks,

David--Alia 2005 (Diskussion) 02:12, 22. Dez. 2013 (CET)

Geburtsdatum

Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 22.12.2013 13:03

1969, June 26th.

Danke

--Alia 2005 (Diskussion) 14:00, 24. Dez. 2013 (CET)

Professor

Neue Mail: Von: "Sinclair, David Andrew" <david_sinclair@hms.harvard.edu> An: "alia@..." Datum: 25.12.2013 01:29

Thank you Alia!

I obtained Bachelor of Science (BSc) with First Class honors at the University of New South Wales (UNSW), Sydney, Australia. Ph.D. in Biochemistry and Molecular genetics.

Ph.D. = Doctor of Philosophy

Yes I am a tenured professor in the Genetics Depertment of Harvard Medical School (HMS), Boston, Massachusetts

Im also a co-joint Professor at the University of New South Wales (UNSW), Sydney, Australia.

David Sinclair is a scientist and entrepreneur working on increasing human health, productivity, and lifespan. After co-discovering a molecular cause of aging at the Massachusetts Institute in Boston in the mid-1990s in the Laboratory of Leonard Guarente, he joined the faculty of Harvard Medical School at the age of 29 as one of their youngest faculty members, where is now a full tenured professor in the Genetics Department. In 2005, he founded the Glenn Laboratories for Aging Research and serves as their Co-Director. He co-founded the Journal Aging in 2009. He is also a Professor at the Lowy Cancer Center at the University of New South Wales in the Department of Pharmacology. His main line of research is aimed at understanding why we grow old and on using this knowledge to prevent and treat both rare and common diseases. His is perhaps best known for identifying resveratrol from red wine as an anti-aging molecule. He has founded five biotechnology companies to treat diseases (Sirtris, NASDAQ: SIRT), improve female reproductive health and IVF (OvaScience, NASDAQ: OVAS), treat type 2 diabetes (Cohbar), to develop vaccines against malaria, chlamydia, tuberculosis, pneumonia, and cancer (Genocea), and to reverse aging and age-related diseases (MetroBiotech). He spoke at TEDx and TEDMED events in 2008 and 2012. He has received numerous awards including The Australian Commonwealth Prize, the Nathan Shock Award and a MERIT Awards from the National Institutes of Health, the Merck Prize, the Genzyme Outstanding Achievement in Biomedical Science Award, the Bio-Innovator award, and Cosmos’ magazine's Bright Sparks award for Top Scientists under 40. He is featured in numerous books including "The Yough Pill" by David Stipp and "Immortal Quest" by Leonard Guarente. A fictional story was written about his research and

Merry Xmas,

David

--Alia 2005 (Diskussion) 05:36, 25. Dez. 2013 (CET)

Defekte Weblinks

Dieser Baustein verhindert die automatische Archivierung dieses Abschnitts und seiner Unterabschnitte.

Der folgende Weblink wurde von einem Bot („GiftBot“) als nicht erreichbar erkannt.
Ausführliche Erläuterungen und Hilfe zur korrekten Behebung dieses Fehlers finden sich auf Wikipedia:Defekte Weblinks. Ist ein von einem Bot als defekt gemeldeter externer Link doch erreichbar, dann bitte berichten – wie auch sonstige Probleme.

• http://www.cosmosmagazine.com/media_room/cosmos-bright-sparks-australias-top-10-young-minds-announced/
  • Vielleicht ist eine archivierte Version geeignet: archive.orghttp://giftbot.dwl.invalid/http://www.cosmosmagazine.com/media_room/cosmos-bright-sparks-australias-top-10-young-minds-announced/

– GiftBot (Diskussion) 05:34, 12. Feb. 2016 (CET)